Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G145904-50 | 50 µg (2.07 mg/ml) | $418 |
| LS-G145904-1 | 1 mg | $2,865 |
Coronavirus SARS-CoV-2 S1 Protein (Recombinant) (Gln14-Arg685) - LS-G145904
Coronavirus SARS-CoV-2 S1 Protein (Recombinant) (Gln14-Arg685) - LS-G145904
Description:
SARS-CoV-2 S1 Protein LS-G145904 is a Recombinant Coronavirus SARS-CoV-2 S1 produced in Human Cells Gln14-Arg685. It is biologically active and is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method).
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
SARS-CoV-2 S1 Protein LS-G145904 is a Recombinant Coronavirus SARS-CoV-2 S1 produced in Human Cells Gln14-Arg685. It is biologically active and is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method).
Specifications
Type
Recombinant Protein
Target
SARS-CoV-2 S1
Synonyms
2019-nCoV S1 Glycoprotein | Wuhan Coronavirus S1 Glycoprotein | SARS-Cov2 (COVID-19) S1 Glycoprotein | SARS-CoV-2 | SARS-Cov2 | COVID-19
Species
Coronavirus SARS-CoV-2
Modifications
Unmodified
Conjugations
Unconjugated
Region
Gln14-Arg685
Predicted Molecular Weight
78.3 kDa
Expression System
Human Cells
Source Species
Human
Purification
Greater than 85 % as determined by reducing SDS-PAGE.
Usage Summary
Recombinant 2019-nCoV S1 Protein is produced by our Mammalian expression system and the target gene encoding Gln14-Arg685 is expressed.
Bio-Activity
Immobilized Human ACE-2-Fc at 10µg/ml (100 µl/well) can bind Recombinant 2019-nCoV S1 Protein . Biotinylated by NHS-biotin prior to testing. The ED50 of Recombinant 2019-nCoV S1 Protein is 1.18 ug/ml.
Endotoxin
Less than 1.0 EU/µg protein (determined by LAL method).
Presentation
Sterile solution in PBS, pH 7.4.
Storage
Store at less than -20°C for up to 6 months. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Publications (0)
Customer Reviews (0)
Images
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Popular SARS-CoV-2 S1 Proteins
Source:
Human
Tag:
6His, C-terminus
Source:
Human
Tag:
6His, C-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/23/2024
Date Requested: 11/23/2024
